The dramatic increase in antibiotic resistance and the recent manifestation in war trauma patients underscore the threat of Acinetobacter baumannii as a nosocomial pathogen. Despite numerous reports documenting its epidemicity, little is known about the pathogenicity of A. baumannii. The aim of this study was to obtain insight into the factors that might explain the clinical success of A. baumannii.
We compared biofilm formation, adherence to and inflammatory cytokine induction by human cells for a large panel of well-described strains of A. baumannii and compared these features to that of other, clinically less relevant Acinetobacter species. Results revealed that biofilm formation and adherence to airway epithelial cells varied widely within the various species, but did not differ among the species. However, airway epithelial cells and cultured human macrophages produced significantly less inflammatory cytokines upon exposure to A. baumannii strains than to strains of A. junii, a species infrequently causing infection.
Citation: de Breij A, Dijkshoorn L, Lagendijk E, van der Meer J, Koster A, Bloemberg G, et al. (2010) Do Biofilm Formation and Interactions with Human Cells Explain the Clinical Success of Acinetobacter baumannii? PLoS ONE 5(5): e10732. https://doi.org/10.1371/journal.pone.0010732
Editor: Olivier Neyrolles, Institut de Pharmacologie et de Biologie Structurale, France
Received: March 26, 2010; Accepted: April 27, 2010; Published: May 20, 2010
Copyright: © 2010 de Breij et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: The authors have no support or funding to report.
Competing interests: The authors have declared that no competing interests exist.
With the recent description of Acinetobacter bereziniae (genomic species (gen. sp.) 10), A. guillouiae (gen. sp. 11) , A. venetianus  and A. soli , the genus Acinetobacter comprises 23 named species and 11 species with provisional designations. Of these, A. baumannii and the closely related A. gen. sp. 3 and 13TU are clinically the most relevant. Strains of these species have the ability to colonize and spread among critically ill hospitalized patients. Outbreaks of multidrug resistant A. baumannii strains have been observed worldwide , . A striking manifestation is the dramatic increase in the frequency of imipenem resistant Acinetobacter isolates in US hospitals  and the recent occurrence of infection in severely injured soldiers during the conflicts in Iraq and Afghanistan . Three major lineages of genetically highly related A. baumannii strains, designated European clone I, II and III, have been found to be frequently implicated in outbreaks , . Other Acinetobacter species, such as A. junii, A. johnsonii and A. lwoffii that can frequently be found on the human skin are only incidentally involved in infection, which usually has a mild course . This suggests differences in the pathogenic potential among Acinetobacter species.
The high prevalence of A. baumannii strains in the hospital in epidemic and endemic situations might be explained by several factors, including their resistance to antibiotics  and desiccation , their ability to form biofilms on medical devices , and to colonize skin and mucosal surfaces of vulnerable hosts , . Adherence of bacteria to host cells is generally considered to be an essential initial step in the colonization process . Once the primary colonizing bacteria have attached to a surface, microcolonies are formed after which bacteria may secrete exopolysaccharides resulting in a highly structured sessile microbial community, the biofilm . Several studies have documented the ability of A. baumannii to adhere to epithelial cells and to form biofilms on glass and plastic surfaces , , . Adherent bacteria can interact with cells of the host defense systems resulting in the release of cellular mediators and effector molecules, such as interleukin (IL)-6 and IL-8 and antimicrobial peptides, which help to eradicate the pathogen .
Little is known about the pathogenicity of A. baumannii. Moreover, the scarce reports on the virulence of A. baumannii are focused on one or a few strains only. The purpose of the present study was to obtain insight into the factors that might explain the clinical success of A. baumannii. To this aim, biofilm formation was investigated for a large set of well-described A. baumannii strains that differed in epidemicity and clonality. Next, biofilm formation by A. baumannii was compared to that of other Acinetobacter species, including A. gen. sp. 3 and 13TU, A. calcoaceticus and A. junii. For a subset of A. baumannii and A. junii strains, adherence to airway epithelial cells and induction of inflammatory cytokine production by these cells and cultured human macrophages was quantitated. Furthermore, the presence of pilus-like structures that may play a role in adherence and biofilm formation was assessed with scanning electron microscopy (SEM).
Biofilm formation on plastic at 28°C and 37°C was first investigated for a comprehensive set of A. baumannii strains. The results revealed a large variation in biofilm formation among A. baumannii isolates; the results at 28°C and 37°C did not differ (Fig. 1). There was no difference in the median biofilm size between strains from outbreaks (0.9; 0–1.8 a.u.) and those not assumed to be from outbreaks (0.8; 0.1–2.8 a.u.). Strains of European clone II (1.1; 0.6–1.8 a.u.) formed larger (p≤0.05) biofilms than strains of clone I (0.8; 0–1.0 a.u.), but not larger than strains of clone III (1.0; 0.6–1.3 a.u.). Multidrug resistant strains (0.8; 0–1.8 a.u.) did not form larger biofilms than susceptible strains (0.8; 0.1–2.8 a.u.). Furthermore, no association between biofilm formation and body site of isolation was found (data not shown).
Biofilm formation after 24 h at 28°C for the clinically relevant A. baumannii (n = 45), A. gen. sp. 3 (n = 3) and A. gen. sp. 13TU (n = 3) and for the clinically less-relevant A. calcoaceticus (n = 3) and A. junii (n = 7). Data are expressed as mean biofilm mass (in arbitrary units (a.u.)) of three independent experiments; each performed in sixplicate. Outbreak-associated (+) or non-outbreak-associated (−) isolate. European clone I (I), II (II) or III (III) isolate. Multidrug resistant (MDR; +) or susceptible (−) isolate.
Next, biofilm formation by A. baumannii strains was compared to that by strains of other Acinetobacter species. No significant differences in the median size of the biofilms at 28°C were found between clinically relevant species, i.e., A. baumannii (0.8; 0–2.8 a.u.), A. gen. sp. 3 (1.4; 1.3–1.5 a.u.) and A. gen. sp. 13TU (0.4; 0.2–0.7 a.u.), and the other Acinetobacter species, i.e., A. calcoaceticus (1.1; 1.0–1.1 a.u.) and A. junii (1.6; 0.5–3.0 a.u.). Similar results were obtained at 37°C except for strains of A. gen. sp. 13TU that formed smaller (p≤0.05) biofilms than all other species. Of note, the number of bacteria in the supernatants at the end of each experiment did not differ much between the different strains (data not shown).
Adherence to human airway epithelial cells
For further comparison of clinically relevant to less-relevant Acinetobacter strains and species, experiments exploring the ability of strains to adhere to and induce cytokines by human cells were conducted with a subset of strains (further referred to as subset), including six strains of A. baumannii and six strains of A. junii, a species infrequently causing infections (Table 1). All selected strains were epidemiologically unrelated and were genotypically diverse as assessed by AFLP genomic fingerprinting.
Adherence to human airway epithelial H292 cells varied widely among the Acinetobacter strains (Table 1). No significant difference in the percentage of H292 cells associated with bacteria was observed between A. baumannii (30; 7–55%) and A. junii (23; 11–70%). In addition, no difference in the number of A. baumannii and A. junii per positive H292 cell was seen; the median number of bacteria per H292 cell was 3 (range 1–5). Of note, differences in the inoculum (within the set range of 7×106–4×107) between the various experiments did not influence the outcome of the adherence assay. Furthermore, cell monolayers remained intact and the morphology of the cells was not affected by the bacteria (data not shown).
Cytokine production by human airway epithelial cells in response to Acinetobacter
Pilot experiments demonstrated that 1×108 CFU bacteria induced higher (p≤0.05) levels of the major cytokines IL-6 and IL-8 in H292 cells than 1×106 and 1×107 CFU did. Furthermore, stimulation with live bacteria resulted in higher (p≤0.05) IL-6 and IL-8 production by H292 cells than heat-inactivated bacteria did. Time-course experiments demonstrated that the levels of IL-6 and IL-8 were higher (p≤0.05) after 24 h than after 6 h stimulation. Therefore, further stimulation experiments were performed for 24 h with 1×108 CFU live bacteria.
Results revealed that H292 cells produced less (p≤0.05) IL-8 in response to A. baumannii strains (1.8; 1.0–3.5 ng/ml) than to A. junii strains (3.2; 2.1–4.9 ng/ml; Fig. 2). Interleukin-6 production was lower in response to A. baumannii strains (1.1; 0.6–2.1 ng/ml) than to strains of A. junii (2.0; 1.4–3.1 ng/ml; Fig. 2), without reaching statistical significance (p = 0.055). Of note, H292 cells stimulated with cytomix produced 2.3 (0.6–3.0) ng/ml IL-6 and 3.4 (1.4–4.1) ng/ml IL-8 and unstimulated cells produced 0.1 (0–0.1) ng/ml IL-6 and 0.2 (0.1–0.2) ng/ml IL-8. Cytokine induction did not vary widely among strains of each species, except for A. baumannii strain LUH7312 that induced significantly higher levels of IL-6 and IL-8 than the other A. baumannii strains. Stimulation of H292 cells with 7 additional A. baumannii strains that were epidemiologically unrelated and genotypically diverse also resulted in low IL-8 (1.3; 0.3–1.7 ng/ml) and IL-6 production (0.1; 0–0.2 ng/ml), demonstrating that, with the exception of strain LUH7312, A. baumannii strains induced significantly (p≤0.01) less IL-6 and IL-8 than A. junii strains.
Boxplots showing IL-6 and IL-8 production in ng/ml by H292 airway epithelial cells 24 h after stimulation with strains of A. baumannii (n = 6) and A. junii (n = 6). Boxes represent medians and second and third interquartiles, whiskers represent range of 6 strains. *significant (p≤0.05) difference between A. baumannii and A. junii.
Since live bacteria were used in this assay, there was a possibility of outgrowth that may have caused the difference in cytokine induction. However, the number of bacteria in the supernatants at the end of each experiment did not differ much between A. baumannii and A. junii (range 8×106–7×107 CFU/ml). Of note, cell monolayers remained intact and the morphology of the cells was not affected by the bacteria (data not shown).
Finally, preliminary experiments demonstrated that exposure of primary human bronchial epithelial cells of a single donor to six A. baumannii strains (in triplicate) resulted in lower (p≤0.05) levels of IL-8 (0.9; 0.5–3.6 ng/ml) than to six A. junii strains (4.5; 0.9–30.7 ng/ml). Cytomix induced 8.6 (7.4–11.5) ng/ml IL-8 in these cells. Of note, no IL-6 was produced by these primary cells upon exposure to these two Acinetobacter species or to cytomix.
Cytokine production by cultured human macrophages in response to Acinetobacter
In tissues, macrophages trigger an adequate innate immune response upon encountering pathogens. In this regulatory process, macrophages serve a dual purpose. Initially, they contribute to the elimination of pathogens and the elicitation of an inflammatory reaction. When the infection recedes due to removal of the pathogens, their function may shift toward resolution of inflammation and tissue repair. In line with this notion, we investigated cytokine production by two clearly distinct types of macrophages, i.e., pro-inflammatory macrophages (further referred to as type 1 macrophages), and macrophages with an anti-inflammatory/pro-angiogenic phenotype (type 2 macrophages) , upon exposure to A. baumannii and A. junii strains. Results revealed that macrophage type 1 produced significantly (p≤0.05) less tumor necrosis factor (TNF)α, IL-12p40, IL-10 and IL-8 in response to strains of A. baumannii [195 (108–244) ng/ml TNFα, 7 (2–11) ng/ml IL-12p40, 22 (0–149) pg/ml IL-10 and 49 (27–66) ng/ml IL-8] than to strains of A. junii [650 (458–812) ng/ml TNFα, 130 (111–155) ng/ml IL-12p40, 764 (126–1587) pg/ml IL-10 and 111 (48–208) ng/ml IL-8; Fig. 3]. A. baumannii strains also induced less (p≤0.05) inflammatory cytokines in macrophage type 2 than A. junii strains (Fig. 3). Of note, cell monolayers remained intact and the morphology of the cells was not affected by the bacteria (data not shown).
Boxplots showing TNFα (A), IL-12p40 (B), IL-8 (C) and IL-10 (D) production by cultured human macrophages type 1 (white boxes) and 2 (gray boxes) 24 h after stimulation with strains of A. baumannii (n = 6), A. junii (n = 6), LPS and without stimulation (none). Boxes represent medians and second and third interquartiles, whiskers represent range of 6 strains (for A. baumannii and A. junii) or range of experiments with 4 different donors (for LPS and none). *significant (p≤0.05) difference between A. baumannii and A. junii.
Electron microscopy analysis of bacterial surface structures
Pili have been described to be involved in biofilm formation, adherence and the induction of an immune response . Therefore, we performed SEM to assess the presence of such surface structures on four A. baumannii strains that differed in their ability to form biofilm and adhere to human cells. SEM of bacteria cultured for 16 h at 37°C on blood agar plates revealed two types of cell appendages: short pilus-like structures and long extensions (Fig. 4). The latter varied in length, were irregularly distributed over the cell surface, and sometimes connected bacteria. The pilus-like structures were detected in A. baumannii strain LUH1398, a large biofilm former and highly adherent, in LUH7312, a small biofilm former and highly adherent, and RUH3023T, a large biofilm former but poorly adherent (Fig. 4, white arrows). Long cell extensions were seen in A. baumannii strain RUH3023T and RUH3239, a small biofilm former and poorly adherent (Fig. 4, black arrows). In addition to these structures, there was a marked surface heterogeneity, from smooth (LUH7312) to pockmarked (LUH1398). In contrast to A. baumannii strain RUH3023T and RUH3239, strain LUH1398 and LUH7312 formed only a few cell clusters with no more than four cells grouped together on the glass slides (data not shown). No difference in structural features was observed between strains cultured at 37°C and 30°C.
This study was undertaken to obtain some insight into the mechanisms underlying the clinical success of A. baumannii. The main conclusion from the present study is that strains of A. baumannii induced a poor inflammatory response in human cells, despite the finding that they adhered well to these cells. This conclusion is based on the following findings.
First, airway epithelial H292 cells in vitro produced less IL-6 and IL-8 in response to A. baumannii strains than to A. junii strains. Furthermore, cultured human macrophages produced less TNFα, IL-12p40, IL-8 and IL-10 in response to A. baumannii strains than to A. junii strains. In agreement with our in vitro data, Qiu et al documented that the high susceptibility of A/J mice to A. baumannii ATCC17961 infection was associated with a reduced local pro-inflammatory response and reduced elimination of bacteria from the lungs . Knapp et al showed in an in vivo model that A. baumannii strain RUH2037 induced the release of pro-inflammatory cytokines and chemokines resulting in clearance of bacteria from the lungs of experimentally infected mice . Although study-design and outcome were distinct from our study, the findings emphasize the importance of inflammatory cytokines for clearing of A. baumannii. It is furthermore of note that our finding that clinically relevant strains induced a weak immune response in vitro has also been reported for Haemophilus influenzae .
There was a wide variation in biofilm formation among a large set of well-described A. baumannii strains. Although epidemic strains did not form larger biofilms than sporadic strains, it appeared that strains of European clone II formed larger biofilms than strains of clone I. It is of note that clone II, which was less frequently involved in outbreaks during the 1990s than clone I, is now emerging in several European countries with many strains being carbapenem resistant , . Further to A. baumannii, the intra-strain variation in biofilm formation of A. gen. sp. 3 and 13TU and of the clinically less-relevant species A. calcoaceticus and A. junii was also considerable. Interestingly, there was no difference between these species, except for A. gen. sp. 13TU that formed small biofilms.
Many of the strains used for the current biofilm experiments had previously been used to investigate adherence to H292 airway epithelial cells . In that study, it was shown that adherence to airway epithelial cells varied considerably among strains of A. baumannii, while strains of clone II had higher adherence values than those of clone I . Likewise, the present study showed a considerable intra-species variation in adherence to human airway epithelial cells but no difference between A. baumannii and A. junii strains. Biofilm formation on plastic was not correlated to adherence to human cells, indicating that different mechanisms are involved in these colonization processes. Furthermore, the ability to form biofilm on plastic and the capacity to adhere to human cells was not always accompanied by the presence of pilus-like cell surface structures and long cell extensions. Taken together, it seems that biofilm formation and adherence to human cells is strain- and not species-specific. Thus, these features do not solely explain the success of A. baumannii in the susceptible host.
In summary, biofilm formation and adherence to airway epithelial cells did not differ between clinically relevant and less-relevant Acinetobacter strains and species. However, there was a difference in the production of inflammatory cytokines by airway epithelial cells and macrophages between A. baumannii and A. junii. This may be a first clue to explain the difference in clinical behavior between A. baumannii and A. junii. We hypothesize that A. baumannii may survive and persist in the airways of patients and cause disease at least in part by inducing a weak inflammatory response.
Materials and Methods
Bacterial strains, culture conditions and antimicrobial susceptibility testing
Forty-five A. baumannii, 3 A. gen. sp. 3, 3 A. gen. sp. 13TU, 3 A. calcoaceticus, and 7 A. junii isolates, were selected from the Leiden University Hospital Acinetobacter collection for this study. Of the A. baumannii strains, 18 were from outbreaks, 16 presumably not from outbreaks on basis of time-space-origin, and 11 of which the association with an outbreak was unknown. Eight of the A. baumannii strains belonged to European clone I, 11 to clone II, and 3 to clone III. All isolates had previously been identified to species by one or more validated genotypic identification methods , , . Bacteria were preserved for prolonged periods in nutrient broth supplemented with 20% (vol/vol) glycerol at -80°C. Prior to each experiment, inocula from frozen cultures were grown overnight at 30°C  on sheep blood agar plates (BioMerieux, Boxtel, the Netherlands). For experiments, fresh subcultures were made either under these conditions or in Luria-Bertani (LB) medium. Susceptibility to antimicrobial agents was determined by disc diffusion according to CLSI recommendations . Strains resistant to more than two of the following drug classes were defined as multidrug resistant: cephalosporins, carbapenems, ampicillin-sulbactam, quinolones, aminoglycosides.
Biofilm formation in 96-wells polyvinylchloride microtiter plates (Falcon, BD, Breda, the Netherlands) was assayed as described . Briefly, bacteria from an overnight culture in LB medium were suspended to 1×106 CFU/ml as calculated from the absorbance of a suspension at 600 nm. Five µl of this suspension was inoculated in 100 µl of M63 medium consisting of KH2PO4 (12 g/l), K2HPO4 (7 g/l), (NH4)2SO4 (2 g/l), glucose (0.2% w/v), MgSO4 (1 mM) and casaminoacids (0.5% w/v). After 24 h incubation at 28°C and 37°C, wells were washed and biofilms attached to the wells were stained with crystal violet (1% w/v). The optical density at 590 nm, expressed in arbitrary units (a.u.), was taken as a quantitative measure of biofilm mass. To determine the bacterial concentration after 24 h, serial dilutions of the supernatants were made in PBS and plated onto blood agar.
Adherence to human airway epithelial cells
Adherence of bacteria to human bronchial epithelial H292 cells (ATCC CRL-1848, Manassas, VA, USA) was determined as described . Briefly, H292 cells were incubated for 1 h at 37°C with 1×107 (range 7×106–4×107) CFU of an overnight culture on blood agar. Bacterial adherence to H292 cells was quantified by light microscopy using two parameters: (i) percentage of epithelial cells associated with at least one bacterium; and (ii) average number of bacteria per epithelial cell .
Cytokine induction in human airway epithelial cells
Cytokine production by airway epithelial cells in response to bacteria was determined as described previously  with minor modifications. In short, bacteria were cultured overnight at 30°C on blood agar and suspended in RPMI-1640 to a concentration of 5×108 CFU/ml as assessed spectrophotometrically. Approximately 2×105 H292 cells were cultured in 0.5 ml of RPMI-1640 supplemented with 2 mM L-glutamine, 50 µg/ml streptomycin, 1000 U sodium penicillin G, and 10% (vol/vol) heat-inactivated foetal calf serum (FCSi), further referred to as culture medium, in 24-wells plates. At 85–90% confluency, H292 cells were washed with prewarmed sterile phosphate buffered saline (PBS; pH 7.4) and incubated at 37°C and 5% CO2 in culture medium without FCSi for 24 h. Subsequently, cells were washed with prewarmed PBS and incubated for 1 h at 37°C and 5% CO2 with 1×106, 1×107, or 1×108 CFU live or heat-inactivated (by 1 h incubation at 100°C) bacteria. H292 cells were washed five times with prewarmed PBS to remove non-adherent bacteria and fresh RPMI-1640 with 2 mM L-glutamine was added. After additional 5 or 23 h incubation at 37°C, supernatants were collected and stored at −20°C. After 24 h, bacterial CFU count in the supernatants was determined. In each experiment, RPMI-1640 with 2 mM L-glutamine alone was added to the cells to determine background values. A mixture of cytokines (100 ng/ml TNFα, 20 ng/ml IL-1β and 10 ng/ml IFNγ; all from Biosource, Nivelles, Belgium) with 10 ng/ml rough type lipopolysaccharide (Escherichia coli J5, Sigma-Aldrich, Zwijndrecht, the Netherlands), further referred to as cytomix, was added to the cells as a positive control.
Cytokine induction in cultured human macrophages
Buffy coats from healthy human donors were purchased from Sanquin bloodbank, Amsterdam, the Netherlands, upon written consent with regard to scientific use. The current study did not require approval from an ethics committee according to the Dutch Medical Research Involving Human Subjects Act. Monocytes were isolated from buffycoats by Ficoll amidotrizoate density centrifugation and magnetic sorting using anti-CD14-coated beads (Miltenyi Biotec, Auburn, CA, USA) according to the manufacturer's instructions. Monocytes were resuspended in culture medium and cultured at a concentration of 2×105 cells/ml in wells of a 24-wells plate at 37°C, 5% CO2 in the presence of either 5 ng/ml recombinant human granulocyte–macrophage colony-stimulating factor (Biosource International, Camarillo, CA, USA) to induce differentiation of monocytes into macrophage type 1 or in the presence of 50 ng/ml recombinant human macrophage colony-stimulating factor (R&D Systems, Minneapolis, MN, USA) for type 2 macrophages . After three days, 0.5 ml of fresh culture medium was added. On the sixth day following isolation, cells were washed once in PBS and 0.5 ml RPMI-1640 with 2 mM L-glutamine was added. Bacteria were cultured overnight at 30°C on blood agar and suspended in PBS to a concentration of 5×107 CFU/ml as assessed spectrophotometrically. Cells were stimulated with 1×107 CFU of live bacteria for 24 h, after which supernatants were collected and stored at −20°C. In each experiment, PBS alone was added to the cells to determine background. Lipopolysaccharide (100 ng/ml, Escherichia coli J5, Sigma-Aldrich) was added to the cells as a positive control.
Determination of levels of inflammatory mediators
The levels of IL-6, IL-8, TNFα, IL-12p40 and IL-10 in culture supernatants were determined by ELISA (Biosource) according to the manufacturer's instructions. The lower limit of detection was 15 pg/ml for IL-6, 7 pg/ml for IL-8, and 25 pg/ml for TNFα, IL-12p40 and IL-10.
Electron microscopy analysis of bacterial surface structures
For SEM, bacteria from an overnight culture on blood agar at 30°C were suspended in PBS and fixed for 1 h at room temperature with 1.5% (w/v) glutaraldehyde in 0.1 M sodium cacodylate buffer (1∶1). Fixed bacteria were transferred to poly-L-lysine-coated glass slides. After 1 h incubation at room temperature, bacteria were fixed to the slides with 1.5% glutaraldehyde for 30 min at room temperature. Thereafter, slides were washed twice in PBS, dehydrated through a series of graded ethanol, critical-point-dried, and coated with a layer of palladium-gold. Bacteria were examined using a JEOL JSM-6700F field emission scanning electron microscope.
Results are expressed as medians and ranges. The Kruskal-Wallis one-way analysis of variance and the Wilcoxon rank sum test were used to evaluate differences in distribution. Spearman rank correlation coefficients were calculated to evaluate possible associations between epidemicity and adherence to epithelial cells and biofilm formation on plastic. P values of ≤0.05 were considered significant.
Conceived and designed the experiments: AdB LD AK GVB PvdB PHN. Performed the experiments: AdB ELL JvdM. Analyzed the data: AdB LD RRW PHN. Contributed reagents/materials/analysis tools: ELL JvdM. Wrote the paper: AdB LD PvdB PHN.
- 1. Nemec A, Musilek M, Sedo O, De Baere T, Maixnerova M, et al. (2010) Acinetobacter berezinae sp. nov. and Acinetobacter guillouiae sp. nov., to accommodate, respectively, Acinetobacter genomic species 10 and Acinetobacter genomic species 11. Int J Syst Evol Microbiol 60: 896–903.A. NemecM. MusilekO. SedoT. De BaereM. Maixnerova2010Acinetobacter berezinae sp. nov. and Acinetobacter guillouiae sp. nov., to accommodate, respectively, Acinetobacter genomic species 10 and Acinetobacter genomic species 11.Int J Syst Evol Microbiol60896903
- 2. Vaneechoutte M, Tjernberg I, Baldi F, Pepi M, Fani R, et al. (1999) Oil-degrading Acinetobacter strain RAG-1 and strains described as ‘Acinetobacter venetianus sp. nov.’ belong to the same genomic species. Res Microbiol 150: 69–73.M. VaneechoutteI. TjernbergF. BaldiM. PepiR. Fani1999Oil-degrading Acinetobacter strain RAG-1 and strains described as ‘Acinetobacter venetianus sp. nov.’ belong to the same genomic species.Res Microbiol1506973
- 3. Kim D, Baik KS, Kim MS, Park SC, Kim SS, et al. (2008) Acinetobacter soli sp nov., isolated from forest soil. J Microbiol 46: 396–401.D. KimKS BaikMS KimSC ParkSS Kim2008Acinetobacter soli sp nov., isolated from forest soil.J Microbiol46396401
- 4. Dijkshoorn L, Nemec A, Seifert H (2007) An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat Rev Microbiol 5: 939–951.L. DijkshoornA. NemecH. Seifert2007An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii.Nat Rev Microbiol5939951
- 5. Peleg AY, Seifert H, Paterson DL (2008) Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 21: 538–582.AY PelegH. SeifertDL Paterson2008Acinetobacter baumannii: emergence of a successful pathogen.Clin Microbiol Rev21538582
- 6. Hoffmann MS, Eber MR, Laxminarayan R (2010) Increasing resistance of Acinetobacter species to imipenem in United States hospitals, 1999–2006. Infect Control Hosp Epidemiol 31: 196–197.MS HoffmannMR EberR. Laxminarayan2010Increasing resistance of Acinetobacter species to imipenem in United States hospitals, 1999–2006.Infect Control Hosp Epidemiol31196197
- 7. Murray CK, Yun HC, Griffith ME, Thompson B, Crouch HK, et al. (2009) Recovery of multidrug-resistant bacteria from combat personnel evacuated from Iraq and Afghanistan at a single military treatment facility. Mil Med 174: 598–604.CK MurrayHC YunME GriffithB. ThompsonHK Crouch2009Recovery of multidrug-resistant bacteria from combat personnel evacuated from Iraq and Afghanistan at a single military treatment facility.Mil Med174598604
- 8. Dijkshoorn L, Aucken H, Gerner-Smidt P, Janssen P, Kaufmann ME, et al. (1996) Comparison of outbreak and nonoutbreak Acinetobacter baumannii strains by genotypic and phenotypic methods. J Clin Microbiol 34: 1519–1525.L. DijkshoornH. AuckenP. Gerner-SmidtP. JanssenME Kaufmann1996Comparison of outbreak and nonoutbreak Acinetobacter baumannii strains by genotypic and phenotypic methods.J Clin Microbiol3415191525
- 9. Van Dessel H, Dijkshoorn L, van der Reijden T, Bakker N, Paauw A, et al. (2004) Identification of a new geographically widespread multiresistant Acinetobacter baumannii clone from European hospitals. Res Microbiol 155: 105–112.H. Van DesselL. DijkshoornT. van der ReijdenN. BakkerA. Paauw2004Identification of a new geographically widespread multiresistant Acinetobacter baumannii clone from European hospitals.Res Microbiol155105112
- 10. Van Looveren M, Goossens H (2004) Antimicrobial resistance of Acinetobacter spp. in Europe. Clin Microbiol Infect 10: 684–704.M. Van LooverenH. Goossens2004Antimicrobial resistance of Acinetobacter spp. in Europe.Clin Microbiol Infect10684704
- 11. Webster C, Towner KJ, Humphreys H (2000) Survival of Acinetobacter on three clinically related inanimate surfaces. Infect Control Hosp Epidemiol 21: 246–246.C. WebsterKJ TownerH. Humphreys2000Survival of Acinetobacter on three clinically related inanimate surfaces.Infect Control Hosp Epidemiol21246246
- 12. Tomaras AP, Dorsey CW, Edelmann RE, Actis LA (2003) Attachment to and biofilm formation on abiotic surfaces by Acinetobacter baumannii: involvement of a novel chaperone-usher pili assembly system. Microbiol 149: 3473–3484.AP TomarasCW DorseyRE EdelmannLA Actis2003Attachment to and biofilm formation on abiotic surfaces by Acinetobacter baumannii: involvement of a novel chaperone-usher pili assembly system.Microbiol14934733484
- 13. Seifert H, Baginski R, Schulze A, Pulverer G (1993) The distribution of Acinetobacter species in clinical culture materials. Zentralbl Bakteriol 279: 544–552.H. SeifertR. BaginskiA. SchulzeG. Pulverer1993The distribution of Acinetobacter species in clinical culture materials.Zentralbl Bakteriol279544552
- 14. Chu YW, Leung CM, Houang ET, Ng KC, Leung CB, et al. (1999) Skin carriage of acinetobacters in Hong Kong. J Clin Microbiol 37: 2962–2967.YW ChuCM LeungET HouangKC NgCB Leung1999Skin carriage of acinetobacters in Hong Kong.J Clin Microbiol3729622967
- 15. Beachey EH, Giampapa CS, Abraham SN (1988) Bacterial adherence. Adhesin receptor-mediated attachment of pathogenic bacteria to mucosal surfaces. Am Rev Respir Dis 138: S45–S48.EH BeacheyCS GiampapaSN Abraham1988Bacterial adherence. Adhesin receptor-mediated attachment of pathogenic bacteria to mucosal surfaces.Am Rev Respir Dis138S45S48
- 16. Costerton JW, Stewart PS, Greenberg EP (1999) Bacterial biofilms: a common cause of persistent infections. Science 284: 1318–1322.JW CostertonPS StewartEP Greenberg1999Bacterial biofilms: a common cause of persistent infections.Science28413181322
- 17. Lee HW, Koh YM, Kim J, Lee JC, Lee YC, et al. (2008) Capacity of multidrug-resistant clinical isolates of Acinetobacter baumannii to form biofilm and adhere to epithelial cell surfaces. Clin Microbiol Infect 14: 49–54.HW LeeYM KohJ. KimJC LeeYC Lee2008Capacity of multidrug-resistant clinical isolates of Acinetobacter baumannii to form biofilm and adhere to epithelial cell surfaces.Clin Microbiol Infect144954
- 18. Lee JC, Koerten H, van den Broek P, Beekhuizen H, Wolterbeek R, et al. (2006) Adherence of Acinetobacter baumannii strains to human bronchial epithelial cells. Res Microbiol 157: 360–366.JC LeeH. KoertenP. van den BroekH. BeekhuizenR. Wolterbeek2006Adherence of Acinetobacter baumannii strains to human bronchial epithelial cells.Res Microbiol157360366
- 19. Kapetanovic R, Cavaillon JM (2007) Early events in innate immunity in the recognition of microbial pathogens. Expert Opin Biol Ther 7: 907–918.R. KapetanovicJM Cavaillon2007Early events in innate immunity in the recognition of microbial pathogens.Expert Opin Biol Ther7907918
- 20. Verreck FA, De Boer T, Langenberg DM, van der Zanden L, Ottenhoff TH (2006) Phenotypic and functional profiling of human proinflammatory type-1 and anti-inflammatory type-2 macrophages in response to microbial antigens and IFN-gamma- and CD40L-mediated costimulation. J Leukoc Biol 79: 285–293.FA VerreckT. De BoerDM LangenbergL. van der ZandenTH Ottenhoff2006Phenotypic and functional profiling of human proinflammatory type-1 and anti-inflammatory type-2 macrophages in response to microbial antigens and IFN-gamma- and CD40L-mediated costimulation.J Leukoc Biol79285293
- 21. Sauer FG, Mulvey MA, Schilling JD, Martinez JJ, Hultgren SJ (2000) Bacterial pili: molecular mechanisms of pathogenesis. Curr Opin Microbiol 3: 65–72.FG SauerMA MulveyJD SchillingJJ MartinezSJ Hultgren2000Bacterial pili: molecular mechanisms of pathogenesis.Curr Opin Microbiol36572
- 22. Qiu H, Kuolee R, Harris G, Chen W (2009) High susceptibility to respiratory Acinetobacter baumannii infection in A/J mice is associated with a delay in early pulmonary recruitment of neutrophils. Microbes Infect 11: 946–955.H. QiuR. KuoleeG. HarrisW. Chen2009High susceptibility to respiratory Acinetobacter baumannii infection in A/J mice is associated with a delay in early pulmonary recruitment of neutrophils.Microbes Infect11946955
- 23. Knapp S, Wieland CW, Florquin S, Pantophlet R, Dijkshoorn L, et al. (2006) Differential roles of CD14 and toll-like receptors 4 and 2 in murine Acinetobacter pneumonia. Am J Respir Crit Care Med 173: 122–129.S. KnappCW WielandS. FlorquinR. PantophletL. Dijkshoorn2006Differential roles of CD14 and toll-like receptors 4 and 2 in murine Acinetobacter pneumonia.Am J Respir Crit Care Med173122129
- 24. Bresser P, van Alphen L, Habets FJ, Hart AA, Dankert J, et al. (1997) Persisting Haemophilus influenzae strains induce lower levels of interleukin-6 and interleukin-8 in H292 lung epithelial cells than nonpersisting strains. Eur Respir J 10: 2319–2326.P. BresserL. van AlphenFJ HabetsAA HartJ. Dankert1997Persisting Haemophilus influenzae strains induce lower levels of interleukin-6 and interleukin-8 in H292 lung epithelial cells than nonpersisting strains.Eur Respir J1023192326
- 25. Da Silva G, Dijkshoorn L, van der Reijden T, van Strijen B, Duarte A (2007) Identification of widespread, closely related Acinetobacter baumannii isolates in Portugal as a subgroup of European clone II. Clin Microbiol Infect 13: 190–195.G. Da SilvaL. DijkshoornT. van der ReijdenB. van StrijenA. Duarte2007Identification of widespread, closely related Acinetobacter baumannii isolates in Portugal as a subgroup of European clone II.Clin Microbiol Infect13190195
- 26. Nemec A, Dijkshoorn L, van der Reijden TJ (2004) Long-term predominance of two pan-European clones among multi-resistant Acinetobacter baumannii strains in the Czech Republic. J Med Microbiol 53: 147–153.A. NemecL. DijkshoornTJ van der Reijden2004Long-term predominance of two pan-European clones among multi-resistant Acinetobacter baumannii strains in the Czech Republic.J Med Microbiol53147153
- 27. Tjernberg I, Ursing J (1989) Clinical strains of Acinetobacter classified by DNA-DNA hybridization. APMIS 97: 595–605.I. TjernbergJ. Ursing1989Clinical strains of Acinetobacter classified by DNA-DNA hybridization.APMIS97595605
- 28. Nemec A, De Baere T, Tjernberg I, Vaneechoutte M, van der Reijden TJ, et al. (2001) Acinetobacter ursingii sp. nov. and Acinetobacter schindleri sp. nov., isolated from human clinical specimens. Int J Syst Evol Microbiol 51: 1891–1899.A. NemecT. De BaereI. TjernbergM. VaneechoutteTJ van der Reijden2001Acinetobacter ursingii sp. nov. and Acinetobacter schindleri sp. nov., isolated from human clinical specimens.Int J Syst Evol Microbiol5118911899
- 29. Dijkshoorn L, van Harsselaar B, Tjernberg I, Bouvet PJ, Vaneechoutte M (1998) Evaluation of amplified ribosomal DNA restriction analysis for identification of Acinetobacter genomic species. Syst Appl Microbiol 21: 33–39.L. DijkshoornB. van HarsselaarI. TjernbergPJ BouvetM. Vaneechoutte1998Evaluation of amplified ribosomal DNA restriction analysis for identification of Acinetobacter genomic species.Syst Appl Microbiol213339
- 30. Hugh R (1978) Classical methods for isolation and identification of glucose nonfermenting Gram-negative rods. R. Hugh1978Classical methods for isolation and identification of glucose nonfermenting Gram-negative rods.In: Gilardi,G L Glucose non-fermeting Gram-negative bacteria in clinical microbiology. CRC Press, West Palm Beach, FL, pp. 3, 6.
- 31. Clinical and Laboratory Standards Institute (2005) Performance Standards for Antimicrobial Susceptibility Testing: Approved Standard M100-S15. Clinical and Laboratory Standards Institute2005Performance Standards for Antimicrobial Susceptibility Testing: Approved Standard M100-S15
- 32. Kuiper I, Lagendijk EL, Pickford R, Derrick JP, Lamers GE, et al. (2004) Characterization of two Pseudomonas putida lipopeptide biosurfactants, putisolvin I and II, which inhibit biofilm formation and break down existing biofilms. Mol Microbiol 51: 97–113.I. KuiperEL LagendijkR. PickfordJP DerrickGE Lamers2004Characterization of two Pseudomonas putida lipopeptide biosurfactants, putisolvin I and II, which inhibit biofilm formation and break down existing biofilms.Mol Microbiol5197113
- 33. Van Wetering S, Mannesse-Lazeroms SPG, van Sterkenburg MAJA, Hiemstra PS (2002) Neutrophil defensins stimulate the release of cytokines by airway epithelial cells: modulation by dexamethasone. Inflamm Res 51: 8–15.S. Van WeteringSPG Mannesse-LazeromsMAJA van SterkenburgPS Hiemstra2002Neutrophil defensins stimulate the release of cytokines by airway epithelial cells: modulation by dexamethasone.Inflamm Res51815